Clinical trials
Diagnosis clinical trials
Below are recruiting diagnosis clinical trials, each written for real people, not researchers. We’re tracking 920 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06278337Recruiting
Moesin-associated immunodeficiency study
This study looks at a rare immune system condition caused by changes in the MOESIN gene. It aims to better understand the condition and may help develop future treatments.
Bethesda, MarylandAges 4–80 - NCT06278532Recruiting
Validating psychosis assessment tools in Lithuanian
This trial tests whether three psychiatric questionnaires work well for people with schizophrenia or related disorders. If you are between 18 and 65 and have one of these diagnoses, joining may help improve care for others like you.
KaunasAges 18–65 - NCT06283797Recruiting
Automated insulin early after type 1 diabetes diagnosis in kids
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
AngersAges 2–18 - NCT06295263Recruiting
AI for diagnosing and treating brain diseases in older adults
This study uses artificial intelligence to help diagnose and treat brain diseases that affect older adults, such as Parkinson's and Alzheimer's. Researchers will compare AI methods with standard care to see if they can improve diagnosis and treatment.
Jinan, ShandongAges 8–100 - NCT06305468Recruiting
Toxoplasmosis prognosis in ICU patients diagnosed by PCR
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
Paris, FranceAges 18–100 - NCT06307990Recruiting
Understanding thyroid hormone response problems
This trial is for people who may have a problem with how their body responds to thyroid hormone. It aims to better understand, diagnose, and monitor these conditions to improve care.
MilanAges Any age - NCT06311838Recruiting
Preventing opioid use among homeless youth
This study tests a program to help homeless youth build social connections and find stable housing to prevent opioid use. It will be conducted by Ohio State University.
Columbus, OhioAges 14–24 - NCT06320236Recruiting
Emergency study on testing for blood clots in the lungs
This study looks at how doctors decide to test for pulmonary embolism (a blood clot in the lungs) in the emergency department. It helps understand what factors lead to testing, which could improve care for future patients.
Hamilton, OntarioAges 18 years+ - NCT06321822Recruiting
Genetic diagnosis and personalized medicine for epilepsy patients
This study aims to find genetic causes of epilepsy and use that information to personalize your care. It involves analyzing your DNA to look for gene changes that may be linked to your seizures.
MilanAges Any age - NCT06324136Recruiting
Personalized diagnosis for rare kidney diseases
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
FlorenceAges birth–70 years - NCT06324565Recruiting
Using D-dimer to find twisted ovaries in teens
This study is checking whether a blood test called D-dimer can help diagnose twisted ovaries (ovarian torsion) in teenage girls. If you have lower belly pain and imaging suggests torsion, this may help doctors catch it sooner.
GrazAges Up to 17 years - NCT06325098Recruiting
Personalized diagnosis for nephrotic syndrome
This study aims to improve how doctors diagnose nephrotic syndrome by using a personalized workflow. If you have nephrotic syndrome and are under 40 years old, this trial might help find the best treatment for your specific type.
FlorenceAges 1 month–40 years - NCT06327269RecruitingEarly Phase 1
Targeted therapy after liver transplant for high-risk liver cancer
This trial tests a targeted therapy (lenvatinib) given after a living-donor liver transplant to prevent high-risk liver cancer from coming back. It is for people whose cancer is aggressive or did not respond well to previous treatments.
Kaohsiung CityAges 18–75 - NCT06335888RecruitingPhase 2
Testing a new imaging agent for large vessel vasculitis
This study tests a special radioactive tracer, 18F-AzaFol, to see if it can help diagnose large vessel vasculitis, a type of inflammation in the arteries. The results will be compared with standard FDG PET/CT scans.
BernAges 50 years+ - NCT06336928Recruiting
Blood test validation for breast cancer diagnosis
This study is testing a new blood test (liquid biopsy) to see if it can accurately detect breast cancer or track remission. If you are a woman getting a mammogram, have an abnormal finding, were recently diagnosed, or are in remission after treatment, you may be able to join and help validate this test.
Los Angeles, CaliforniaAges 18 years+ - NCT06339190Recruiting
Testing blood and voice for early dementia diagnosis
This study uses a simple blood test (neurofilament light chain) and a voice recording analysis to see if they can help diagnose dementia earlier. Researchers want to see if these markers can reliably detect brain changes in people with memory or thinking problems.
Box Hill, VictoriaAges Any age - NCT06339801Recruiting
Mucosal impedance test for GERD diagnosis
This study tests a new way to measure how your esophagus lining reacts to acid (called mucosal impedance) to help diagnose GERD. It's for people who still have symptoms even after taking standard medication for 8 weeks.
Buenos AiresAges 18–65 - NCT06355245Recruiting
Early cancer detection study for unexplained symptoms
This study looks for early signs of cancer in people who have unexplained symptoms like extreme tiredness, weight loss, fever, or abnormal lab tests. You will be monitored and tested to see if markers can find cancer sooner.
StockholmAges 18 years+ - NCT06364397Recruiting
ERCP for unexplained recurrent pancreatitis
This study tests whether a procedure called ERCP can help find and treat the cause of recurrent pancreatitis that remains unexplained after standard tests.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06369714Recruiting
Brain-training video game for ADHD in children
This trial tests a digital therapy that uses neurofeedback (brainwave training) to help children with ADHD improve focus and attention. It's designed for kids ages 6 to 11 who haven't had ADHD treatment in the last month.
Shanghai, Shanghai MunicipalityAges 6–12 - NCT06370481Recruiting
HIV and addiction training program for Alabama clinics
This study tests a program to help people living with HIV in Alabama who also struggle with opioid or stimulant use. It takes place at your HIV clinic and checks whether a new approach to addiction care can improve your health.
Birmingham, AlabamaAges 18 years+ - NCT06375447Recruiting
Smart model for diagnosing and treating insomnia
This trial is testing a new intelligent approach to diagnose and treat insomnia. If you have trouble sleeping and are between 18 and 75, you may be able to join and help improve insomnia care.
BeijingAges 18–75 - NCT06378619Recruiting
Using a tap test and spiral drawing to diagnose tremors
This study uses a simple tapping test and drawing a spiral (like on paper) to tell the difference between tremors caused by Parkinson's disease and essential tremor. It may help you get a more accurate diagnosis without extra procedures.
Barcelona, CataloniaAges 45–79 - NCT06380777Recruiting
Digital system for diagnosing and treating sarcopenia
This study is testing a new digital system to help diagnose and manage sarcopenia (age-related muscle loss). It aims to make it easier for doctors to track and treat muscle loss, which can improve your strength and quality of life.
Beijing, Beijing MunicipalityAges 45 years+
Hear when a new Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diagnosis?
- Yes. Clin2 currently lists 920 recruiting diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.